SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences (SLS) is trending as investors react to a recent SEC filing regarding executive change-of-control agreements, which many in the community view as a strategic precursor to a potential buyout. The stock is also seeing significant upward momentum fueled by extreme short-squeeze conditions, including ultra-high borrow fees and a massive, trapped short position ahead of an anticipated clinical readout.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is facing intense selling pressure and significant community debate as its leveraged position in Bitcoin and complex dividend structure trigger concerns about a potential death spiral. Investors are actively split between those who view the current price drop as a generational buying opportunity and critics who fear forced liquidations and dilution will drive the stock toward bankruptcy.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is trending as investors react to new government executive orders and federal initiatives that fast-track quantum computing, positioning the company as a key player in national security. The community is actively discussing the stock's role in government-backed projects, the impact of its upcoming Russell index inclusion, and high-conviction options activity while speculating on the company's long-term growth potential.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors weigh the stock's recent pullback against upcoming catalysts, including the June EMA regulatory decision and the July 1 implementation of a permanent J-code for Yartemlea. The community is actively discussing the stock's valuation, questioning management's communication strategy, and debating the potential impact of short interest versus the company's long-term commercial potential.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing significant downward pressure and intense community scrutiny as investors react to a leadership transition and ongoing skepticism regarding the company's turnaround timeline before upcoming earnings. While some see a value opportunity in the brand's long-term global presence, many traders are vocal about the persistent downtrend and competitive challenges from emerging athletic brands.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is drawing significant investor attention following its announcement of a seven-billion-dollar all-stock acquisition of Synaptics, a move intended to bolster its leadership in physical AI, power efficiency, and edge computing. While the strategic consolidation is viewed by many as a vital play for long-term dominance in AI-enabled infrastructure, the market is actively debating the deal's valuation and the short-term pressure on share price resulting from the merger terms.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio is trending as investors react to the company's recent move to replace high-interest secured debt with $250 million in low-interest convertible notes, a strategic financial restructuring that analysts view as a sign of institutional confidence. While some retail investors initially expressed concerns over potential dilution, the community is focused on the debt-free balance sheet improvements, the protection provided by capped calls, and the bolstered cash position for advancing their Ibtrozi and Safusidenib pipelines.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMC is trending due to rising foundry prices on advanced nodes, a move highlighting the company's robust pricing power as it manages supply-demand imbalances in the booming AI infrastructure market. Community members are actively debating the long-term impact of its capacity bottlenecks, the sustainability of the semiconductor super-cycle, and whether current valuation levels offer a compelling entry point for long-term investors.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Bitcoin is experiencing heightened volatility as investors grapple with shifting macroeconomic data, geopolitical tensions in the Middle East, and the influence of heavy institutional ETF inflows. The community remains deeply divided, with bulls pointing to long-term adoption and institutional stability, while bears cite concerns over intrinsic value and the potential for a deeper market correction.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is gaining significant momentum as analysts at TD Cowen name it their top small-mid cap idea for 2026, pointing to strong store growth and an underappreciated food rollout as major catalysts. The community remains divided, with bulls highlighting the brand's immense popularity and expansion, while skeptics express concern over valuation multiples and the impact of broader consumer economic pressures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HSTM ripping higher into the close and showing real juice after that Q1 beat. 
 
Check it: $HSTM is up strong with shares trading around mid‑20s action, pushing past yesterday’s levels and pulling a fresh bid into late session. Earnings came in hotter than analyst targets with EPS of $0.20 vs expectations of ~$0.17 and revenue up ~10.5% YOY, giving bulls something to latch onto. 
 
The intraday price action is showing buyers stepping in off key support, and with a new dividend announced plus a $10M buyback in place, the setup is acting like a squeeze on lighter supply. 
 
If this close holds, we’re looking at follow‑through momentum into tomorrow’s open with conviction from both fundamentals and tape. Don’t blink.

StockTwits Web

Healthstream Inc

HSTM ripping higher into the close and showing real juice after that Q1 beat. 
 
Check it: 

 is up strong with shares trading around mid‑20s action, pushing past yesterday’s levels and pulling a fresh bid into late session. Earnings came in hotter than analyst targets with EPS of $0.20 vs expectations of ~$0.17 and revenue up ~10.5% YOY, giving bulls something to latch onto. 
 
The intraday price action is showing buyers stepping in off key support, and with a new dividend announced plus a $10M buyback in place, the setup is acting like a squeeze on lighter supply. 
 
If this close holds, we’re looking at follow‑through momentum into tomorrow’s open with conviction from both fundamentals and tape. Don’t blink.